AdobeStock_212764468

Working party guideline/algorithm

Identifying and managing allergic rhinitis in the asthma population

2020-08-23T04:00:00+01:00By Development Group—Scadding Holmes Ryan and Williams

Information is intended for healthcare professionals

An inhaler in WPG Yellow

Working party guideline/algorithm

Inhaler choice guideline

2020-07-31T08:50:00+01:00By Development group—Usmani Capstick Saleem Scullion

Information is intended for healthcare professionals only.

doctor writing

Independent professional body guideline

GINA strategy 2020: assessing patients with asthma

2020-07-20T13:25:00+01:00By

This Guidelines summary outlines recommendations for assessing patients with asthma. Please refer to the full report for the complete set of recommendations.

doctor writing notes holding inhaler

Independent professional body guideline

GINA strategy 2020: asthma–COPD overlap

2020-07-20T13:24:00+01:00By

This Guidelines summary outlines recommendations for the diagnosis and initial treatment of adults with features of asthma, chronic obstructive pulmonary disease (COPD), or both. 

doctor with inhalers

Independent professional body guideline

GINA strategy 2020: management of asthma

2020-07-20T13:24:00+01:00By

This Guidelines summary outlines recommendations for the management of asthma in adults, adolescents, and children aged six to 11.

doctor with inhalers

Independent professional body guideline

GINA strategy 2020: diagnosis of asthma

2020-07-20T13:17:00+01:00By

This Guidelines summary outlines recommendations for making the diagnosis of asthma in adults and children over five years of age. Please refer to the full report for the complete set of recommendations.

Pneumonia

NICE guideline

COVID-19 rapid guideline: pneumonia in adults

2020-04-27T00:11:00+01:00By

The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic.

AdobeStock_301114385

NICE guideline

COVID-19 rapid guideline: cystic fibrosis

2020-04-21T14:26:00+01:00By

The purpose of this Guidelines summary is to maximise the safety of patients with cystic fibrosis and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match capacity to patient needs if services become limited because of the COVID-19 pandemic.

AdobeStock_332747243

NICE guideline

COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD)

2020-04-17T17:02:00+01:00By

The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.

AdobeStock_289304487

NICE guideline

COVID-19 rapid guideline: severe asthma

2020-04-17T13:39:00+01:00By

The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.

Resource hub

  • Inhaler standards and competency document

Educational resources

AdobeStock_212764468

Working party guideline/algorithm

Identifying and managing allergic rhinitis in the asthma population

By Development Group—Scadding Holmes Ryan and Williams

Information is intended for healthcare professionals

An inhaler in WPG Yellow

Working party guideline/algorithm

Inhaler choice guideline

By Development group—Usmani Capstick Saleem Scullion

Information is intended for healthcare professionals only.

Final version (DIGITAL) - G4N Respimat supplement

Supplement

The re-usable Respimat® Soft Mist™ inhaler

Commissioned by Boehringer Ingelheim Limited

Information for healthcare professionals only.